( EuronextParis:SAN, NYSE:SNY )

News from Sanofi A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

22 May, 2017, 17:47 ET Sanofi and Regeneron Announce FDA Approval of Kevzara® (sarilumab) for the Treatment of Moderately to Severely Active Rheumatoid Arthritis in Adult Patients

Sanofi and Regeneron Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) approval of Kevzara® (sarilumab) for the...


11 May, 2017, 08:30 ET Allegra® Allergy Gears Up for Bike to Work Day Across the U.S.

Sanofi Consumer Healthcare – the makers of Allegra® Allergy – announced today that it is supporting Bike to Work Day events across the country as a...


02 May, 2017, 08:30 ET Survey Results Show Eighty Percent of Rheumatoid Arthritis Patients Report Life-Altering Pain Daily or Multiple Times a Week, Despite Treatment

Honestly RA, a new survey of more than 1,000 people in the United States living with rheumatoid arthritis (RA), found that even after treatment,...


28 Apr, 2017, 07:30 ET Sanofi Delivers Robust Q1 2017 Financial Results

Sanofi (NYSE: SNY; EURONEXT: SAN) Q1 2017 Change Change at CER Change...


25 Apr, 2017, 08:00 ET Sanofi and Regeneron Announce FDA Approval of a New Once-Monthly Dosing Option for Praluent® (alirocumab) Injection

Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved the companies' new...


03 Apr, 2017, 09:00 ET Sanofi Launches First-Ever ACT® Kids Toothpaste in the U.S.

Sanofi announced today the launch of ACT® Kids Toothpaste, a new anti-cavity fluoride toothpaste that is specially developed for kids two years of...


03 Apr, 2017, 09:00 ET Sanofi lanza la primera ACT® Kids Toothpaste en Estados Unidos

Sanofi anunció hoy el lanzamiento de ACT® Kids Toothpaste, una nueva pasta dental anticaries con fluoruro que ha sido creada especialmente para los...


02 Apr, 2017, 13:01 ET Switching to Sanofi's Toujeo® Showed Significant Reductions in Blood Sugar and Significantly Lower Incidence of Hypoglycemia in a Real-World Observational Study

Sanofi announced today the presentation of a new observational study1 in real-world clinical practice demonstrating significantly lower risk of...


28 Mar, 2017, 11:40 ET Sanofi and Regeneron Announce FDA Approval of Dupixent® (dupilumab), the First Targeted Biologic Therapy for Adults with Moderate-to-Severe Atopic Dermatitis

Sanofi and Regeneron Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) approved Dupixent® (dupilumab)...


22 Mar, 2017, 07:30 ET Sanofi Genzyme Extends its Multiple Myeloma Journey Partners Program to Cities Nationwide to Help Improve Patient Outcomes through Peer-to-Peer Education

Sanofi Genzyme, the specialty care global business unit of Sanofi, today announced the extension of the Multiple Myeloma Journey Partners Program...


21 Mar, 2017, 07:30 ET Sanofi Announces Results of First-of-Its-Kind Social Experiment Revealing Real-Life Impact of Symptoms on Allergy Sufferers in the U.S.

Sanofi Consumer Healthcare – the makers of new Xyzal® Allergy 24HR, which is now available on retail shelves nationwide – revealed today the...


27 Feb, 2017, 08:30 ET Sanofi and Regeneron to Present New Data on Dupixent® (dupilumab) for Moderate-to-Severe Atopic Dermatitis at Upcoming Medical Congresses

Sanofi and Regeneron Pharmaceuticals, Inc. today announced that detailed results from the Phase 3 CHRONOS study will be presented as a...


08 Feb, 2017, 07:30 ET Sanofi Delivers 2016 Sales and Business EPS Growth at CER

Sanofi (NYSE: SNY; EURONEXT: SAN) Q4 2016 Change Change (CER) 2016...


08 Feb, 2017, 03:05 ET Sanofi - Interview du Directeur Général - Résultats 2016 (vidéo)

Sanofi, un leader mondial et diversifié de la santé, publie ses résultats pour l'année 2016. Le Directeur Général du Groupe, Olivier Brandicourt,...


08 Feb, 2017, 03:02 ET Sanofi CEO Interview - FY 2016 Results (video)

Sanofi, a global and diversified healthcare leader, reports results for 2016. Olivier Brandicourt, Chief Executive Officer of Sanofi, comments on...


01 Feb, 2017, 08:00 ET Sanofi's Xyzal® Allergy 24HR Approved for Over-the-Counter Use in the United States

Sanofi announced today that the U.S. Food and Drug Administration (FDA) approved Xyzal® Allergy 24HR as an over-the-counter (OTC) treatment for the...


09 Jan, 2017, 08:00 ET Sanofi and ImmuNext Enter into Agreement to Develop Treatments for Autoimmune Diseases

Sanofi and ImmuNext, Inc., announced today an agreement focused on the development of a novel antibody with the potential to treat a range...


04 Jan, 2017, 08:00 ET Sanofi Announces Soliqua™ 100/33 Now Available in the U.S.

Sanofi announced today that Soliqua™ 100/33 (insulin glargine 100 Units/mL & lixisenatide* 33 mcg/mL injection) is now available by...


12 Dec, 2016, 12:29 ET Scottish Medicines Consortium Approves Sanofi Prostate Cancer Drug

Jevtana® (cabazitaxel) for Men With Metastatic Hormone-refractory Prostate Cancer Accepted for Routine use in NHS Scotland Sanofi Genzyme, the...


21 Nov, 2016, 19:19 ET Sanofi Receives FDA Approval of Soliqua™ 100/33 for the Treatment of Adults with Type 2 Diabetes

Sanofi announced today that the U.S. Food and Drug Administration (FDA) approved once-daily Soliqua™ 100/33 (insulin glargine & lixisenatide...


17 Nov, 2016, 16:01 ET New Survey Finds Men in the U.S. Want to Take Charge of Their Own Health and Wellness

A new survey reveals that 90% of men in the U.S. want to take charge of their own health. The U.S. is one of eight countries that participated in...


28 Oct, 2016, 08:14 ET Sanofi Announces Strong Q3 2016 Results

Sanofi (NYSE: SNY; EURONEXT: SAN) Q3 2016 Change Change (CER)...


28 Oct, 2016, 03:43 ET Sanofi - Interview du Directeur Financier - Résultats T3 2016 (vidéo)

Sanofi, un leader mondial et diversifié de la santé, publie ses résultats pour le troisième trimestre 2016. Le Directeur Financier du Groupe,...


28 Oct, 2016, 03:42 ET Sanofi CFO Interview - Q3 2016 Results (Video)

Sanofi, a global and diversified healthcare leader, reports results for the third quarter of 2016. Jérôme Contamine, Chief Financial Officer of...


05 Oct, 2016, 08:30 ET New Survey Reveals the Widespread and Serious Impact of Moderate-to-Severe Atopic Dermatitis on People Living with the Disease

 A new survey of 505 American adults (18 years of age and older) who self-reported being diagnosed with moderate-to-severe atopic dermatitis...